Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 1/20 | 0.55 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.55 |
| ▸ | KIT | P10721 | 9/20 | 0.43 |
| ▸ | BRAF | P15056 | 9/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
| ▸ | TLK2 | Q86UE8 | 1/20 | 0.41 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.40 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.40 |
| ▸ | BCL6 | P41182 | 1/20 | 0.40 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.40 |
| ▸ | TYK2 | P29597 | 1/20 | 0.40 |
| ▸ | FLT1 | P17948 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4042030 | 0.93 | JAK3 (0.47) | JAK3IRAK4KITBRAFFLT1 | |
| SCHEMBL4034865 | 0.92 | IRAK4 (0.53) | JAK3IRAK4KITBRAFCRBN | |
| SCHEMBL6612511 | 0.88 | JAK3 (0.53) | JAK3IRAK4KITBRAF | |
| SCHEMBL6542947 | 0.87 | JAK3 (0.59) | JAK3IRAK4KITBRAFTLK2 | |
| SCHEMBL4034704 | 0.86 | JAK3 (0.46) | JAK3IRAK4KITBRAFFLT1 | |
| SCHEMBL4036359 | 0.85 | JAK3 (0.54) | JAK3IRAK4KITBRAFCRBN | |
| SCHEMBL4034859 | 0.84 | IRAK4 (0.56) | JAK3IRAK4KITBRAFCRBN | |
| SCHEMBL4036464 | 0.83 | JAK3 (0.52) | JAK3IRAK4KITBRAFCRBN | |
| SCHEMBL4040691 | 0.81 | JAK3 (0.51) | JAK3IRAK4KITBRAF | |
| SCHEMBL6543366 | 0.80 | KIT (0.64) | JAK3IRAK4KITBRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1392680-B1 | SELECTIVE ANTHRANILAMIDE PYRIDINE AMIDES AS INHIBITORS OF VEGFR-2 AND VEGFR-3 | BAYER SCHERING PHARMA AG (DE) | 2009-07-22 | — | — | EP | disclosed |
| EP-1392680-A2 | SELECTIVE ANTHRANILAMIDE PYRIDINE AMIDES AS INHIBITORS OF VEGFR-2 AND VEGFR-3 | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-03-03 | — | — | EP | disclosed |
| WO-2002090352-A2 | SELECTIVE ANTHRANILAMIDE PYRIDINE AMIDES AS INHIBITORS OF VEGFR-2 AND VEGFR-3 | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-11-14 | — | — | WO | disclosed |